NCT03087903View on ClinicalTrials.gov

A Study of Grape Seed Extract in Asymptomatic Non-Metastatic Prostate Cancer Patients With Rising PSA

NACompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

January 18, 2018

Primary Completion Date

September 29, 2023

Study Completion Date

September 29, 2023

Conditions
Prostate Cancer
Interventions
DIETARY_SUPPLEMENT

Grape Seed Extract

Patients will take 150 mg of Grape Seed Extract (GSE) product by mouth twice daily (in the form of 75 mg capsule of Leucoselect Phytosome preparation). Total oral dosage is 300 mg of GSE per day for one year. Patients will be evaluated every 6 weeks for 3 months, then every 3 months thereafter for up to one year. PSA measurements will be obtained at these scheduled visits.

Trial Locations (2)

80045

University of Colorado Cancer Center, Aurora

80524

Poudre Valley Hospital, Fort Collins

All Listed Sponsors
collaborator

Cancer League of Colorado

OTHER

lead

University of Colorado, Denver

OTHER

NCT03087903 - A Study of Grape Seed Extract in Asymptomatic Non-Metastatic Prostate Cancer Patients With Rising PSA | Biotech Hunter | Biotech Hunter